sacituzumab govitecan
gilead sciences
['tropics-02', 'mbc', 'sacituzumab govitecan']
tropics-02 trial: in heavily pretreated #mbc sacituzumab govitecan vs tpc:
- pfs: 5.5 vs 4.0 mo (hr 0.66, p=0.0003)
- os data is not yet mature at ia1
- orr: 21 vs 14% (odds ratio 1.63, p=0.03)
- cbr: 34 vs 22% (odds ratio 1.84, p=0.002) #asco22 #bcareporter 